Landing B H, Wells T R, Lipsey A I, Oyemade O A
Department of Pathology, Childrens Hospital of Los Angeles, California 90027.
Pediatr Pathol. 1990;10(6):959-72. doi: 10.3109/15513819009064730.
Portal tract fibrosis with biliary ductular enlargement or proliferation occurs in a number of genetic diseases that have cystic or tubulointerstitial renal lesions. These include some with renal cystic disease such as autosomal recessive diseases (e.g., infantile polycystic disease, juvenile polycystic disease, and Meckel's syndrome), autosomal dominant diseases (e.g., adult polycystic disease) and, rarely, tuberose sclerosis and dominant glomerulocystic disease. Portal tract fibrosis with biliary enlargement and proliferation occurs also with tubulointerstitial kidney diseases. These probably include at least three disorders in the category nephronophthisis-congenital hepatic fibrosis (one autosomal recessive disease and two either autosomal or X-linked recessive diseases) plus Jeune's syndrome (the tubulointerstitial diseases Fanconi's familial nephronophthisis and anti-tubular membrane antibody disease do not regularly cause hepatic fibrosis). Morphometric data on ratios of bile ductules to connective tissue in hepatic portal tracts show high values for infantile polycystic disease (mean, 0.616) compared to lower values for juvenile polycystic disease (mean, 0.286). That the cystic renal lesions of the first two diseases differ in type and time course is known. Similar data on ratios of glomeruli plus tubules to connective tissue in renal cortices and of tubules to connective tissue in outer medullary zones of kidneys, respectively, are as follows: for Fanconi's nephronophthisis, 0.445 and 0.197; for anti-tubular basement membrane antibody disease, 0.585 and 0.164; and for the three types of nephronophthisis-congenital hepatic fibrosis studied, 0.668 and 0.446, 1.39 and 0.921, and 1.18 and 0.12. These data support clinical impressions that the category nephrophthisis-congenital hepatic fibrosis includes more than one disease entity.
门管区纤维化伴胆小管增大或增生见于多种伴有囊性或肾小管间质性肾损害的遗传性疾病。这些疾病包括一些肾囊性疾病,如常染色体隐性疾病(如婴儿型多囊病、青少年型多囊病和梅克尔综合征)、常染色体显性疾病(如成人型多囊病),以及罕见的结节性硬化症和显性肾小球囊性疾病。门管区纤维化伴胆小管增大和增生也见于肾小管间质性肾病。这可能至少包括肾痨 - 先天性肝纤维化类别中的三种疾病(一种常染色体隐性疾病和两种常染色体或X连锁隐性疾病)加琼氏综合征(肾小管间质性疾病范科尼家族性肾痨和抗肾小管膜抗体病通常不会引起肝纤维化)。肝门管区胆小管与结缔组织比例的形态计量学数据显示,婴儿型多囊病的值较高(平均值为0.616),而青少年型多囊病的值较低(平均值为0.286)。前两种疾病的囊性肾损害在类型和病程上不同是已知的。分别关于肾皮质中肾小球加肾小管与结缔组织的比例以及肾外髓质区中肾小管与结缔组织的比例的类似数据如下:范科尼肾痨为0.445和0.197;抗肾小管基底膜抗体病为0.585和0.164;以及所研究的三种肾痨 - 先天性肝纤维化类型为0.668和0.446、1.39和0.921,以及1.18和0.12。这些数据支持临床印象,即肾痨 - 先天性肝纤维化类别包括不止一种疾病实体。